RANKL promotes the growth of decidual stromal cells in an autocrine manner via CCL2/CCR2 interaction in human early pregnancy

Placenta

Volumn 34, Issue 8, 2013, Pages 663-671

  Meng, Y H ^a   Li, H ^a   Chen, X ^a   Liu, L B ^a   Shao, J ^a   Chang, K K ^a   Du, M R ^a   Jin, L P ^a   Li, M Q ^a   Li, D J ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

CCR2; DSCs; Early pregnancy; Proliferation; RANK; RANKL

Indexed keywords

CHEMOKINE RECEPTOR CCR2; FAS LIGAND; KI 67 ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CYTOKINE RELEASE; DECIDUALIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; STROMA CELL;

EID: 84882454504     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2013.04.020     Document Type: Article

References (52)

1. Tang B, Guller S, Gurpide E. Mechanisms of human endometrial stromal cell decidualization. Ann N Y Acad Sci 1994;734:19-25.
2. Maruyama T, Yoshimura Y. Molecular and cellular mechanisms for differentiation and regeneration of the uterine endometrium. Endocr J 2008;55: 795-810.
3. Salamonsen LA, Dimitriadis E, Jones RL, Nie G. Complex regulation of decidualization: a role for cytokines and proteasesda review. Placenta 2003;24:S76-85.
4. Pijnenborg R, Dixon G, Robertson WB, Brosens I. Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1980;1:3-19.
5. Edwards RG. Implantation, interception and contraception. Hum Reprod 1994;9:985-95.
6. Maslar IA, Ansbacher R. Effect of short-duration progesterone treatment on decidual prolactin production by cultures of proliferative human endometrium. Fertil Steril 1988;50:250-4.
7. Golander A, Zakuth V, Shechter Y, Spirer Z. Suppression of lymphocyte reactivity in vitro by a soluble factor secreted by explants of human decidua. Eur J Immunol 1981;11:849-51.
8. Daly DC, Maslar IA, Riddick DH. Prolactin production during in vitro decidualization of proliferative endometrium. Am J Obstet Gynecol 1983;145:672-8.
9. Huang JR, Tseng L, Bischof P, Janne OA Regulation of prolactin production by progestin, estrogen, and relaxin in human endometrial stromal cells. Endocrinology 1987;121:2011-7.
10. Karpovich N, Klemmt P, Hwang JH, Mc Veigh JE, Heath JK, Barlow DH, et al. The production of interleukin-11 and decidualization are compromised in endometrial stromal cells derived from patients with infertility. J Clin Endocrinol Metab 2005;90:1607-12.
11. Jones RL, Salamonsen LA, Findlay JK. Activin A promotes human endometrial stromal cell decidualization in vitro. J Clin Endocrinol Metab 2002;87:4001-4.
12. Dimitriadis E, Stoikos C, Baca M, Fairlie WD, Mc Coubrie JE, Salamonsen LA. Relaxin and prostaglandin E2 regulate interleukin 11 during human endometrial stromal cell decidualization. J Clin Endocrinol Metab 2005;90: 3458-65.
13. Irwin JC, de las Fuentes L, Giudice LC. Growth factors and decidualization in vitro. Ann N Y Acad Sci 1994;734:7-18.
14. Zoumakis E, Margioris AN, Stournaras C, Dermitzaki E, Angelakis E, Makrigiannakis A, et al. Corticotrophin-releasing hormone (CRH) interacts with inflammatory prostaglandins and interleukins and affects the decidualization of human endometrial stroma. Mol Hum Reprod 2000;6:344-51.
15. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, et al. Osteo-protegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-76.
16. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997;390:175-9.
17. Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 1997;272:25190-4.
18. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL Proc Natl Acad Sci USA 1998;95:3597-602.
19. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, et al. OPGLis a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999;397:315-23.
20. Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, et al. RANK is essential for osteoclast and lymph node development. Genes Dev 1999;13:2412-24.
21. Rossi SW, Kim MY, Leibbrandt A, Parnell SM,Jenkinson WE, Glanville SH, et al. RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla. J Exp Med 2007;204: 1267-72.
22. Fata JE, Kong YY, Li J, Sasaki T, Irie-Sasaki J, Moorehead RA, et al. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 2000;103:41-50.
23. Cao Y, Bonizzi G, Seagroves TN, Greten FR, Johnson R, Schmidt EV, et al. IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell 2001;107:763-75.
24. Schramek D, Leibbrandt A, Sigl V, Kenner L, Pospisilik JA, Lee HJ, et al. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 2010;468:98-102.
25. Jones DH, Nakashima T, Sanchez OH, Kozieradzki I, Komarova SV, Sarosi I, et al. Regulation of cancer cell migration and bone metastasis by RANKL. Nature 2006;440:692-6.
26. Hanada R, Hanada T, Sigl V, Schramek D, Penninger JM. RANKL/RANK-beyond bones. J Mol Med 2011;89:647-56.
27. Theill LE, Boyle WJ, Penninger JM. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol 2002;20:795-823.
28. Hanada R, Leibbrandt A, Hanada T, Kitaoka S, Furuyashiki T, Fujihara H, et al. Central control of fever and female body temperature by RANKL/RANK. Nature 2009;462:505-9.
29. Li MQ, Hou XF, Shao J, Tang CL, Li DJ. DSCs-expressed CD82 promoted the expression of TIMP1 and inhibited the invasion of trophoblast cells by integrinb 1/MAPK/Erk1/2 signaling pathway at materno-fetal interface of human first-trimester pregnancy. Biol Reprod 2010;82:968-79.
30. Li MQ, Luo XZ, Meng YH, Mei J, Zhu XY, Jin LP, et al. CXCL8 enhances proliferation and growth and reduces apoptosis in endometrial stromal cells in an autocrine manner via a CXCR1-triggered PTEN/AKT signal pathway. Hum Reprod 2012;27:2107-16.
31. Kim MS, Day CJ, Morrison NA. MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of oste-oclast formation. J Biol Chem 2005;280:16163-9.
32. Kim MS, Magno CL, Day CJ, Morrison NA. Induction of chemokines and che-mokine receptors CCR2b and CCR4 in authentic human osteoclasts differentiated with RANKL and osteoclast like cells differentiated by MCP-1 and RANTES. J Cell Biochem 2006;97:512-8.
33. He YY, Du MR, Gou PF, He XJ, Zhou WH, Zhu XY, et al. Regulation of C-C motif chemokine ligand2 and its receptor in human decidual stromal cells by pregnancy-associated hormones in early gestation. Hum Reprod 2007;22: 2733-42.
34. Li MQ, Li HP, Meng YH, Wang XQ, Zhu XY, Mei J, et al. Chemokine CCL2 enhances survival and invasiveness of endometrial stromal cells in an autocrine manner by activating Akt and MAPK/Erk1/2 signal pathway. Fertil Steril 2012;97:919-29.
35. Ren L, Liu YQ, Zhou WH, Zhang YZ. Trophoblast-derived chemokine CXCL12 promotes CXCR4 expression and invasion of human first-trimester decidual stromal cells. Hum Reprod 2012;27:366-74.
36. Dimitriadis E, White CA, Jones RL, Salamonsen LA. Cytokines, chemokines and growth factors in endometrium related to implantation. Hum Reprod Update 2005;11:613-30.
37. Lockwood CJ, Krikun G, Hickey M, Huang SJ, Schatz F. Decidualized human endometrial stromal cells mediate hemostasis, angiogenesis, and abnormal uterine bleeding. Reprod Sci 2009;16:162-70.
38. He YY, He XJ, Guo PF, Du MR, Shao J, Li MQ, et al. The decidual stromal cells-secreted CCL2 induces and maintains decidual leukocytes into Th2 bias in human early pregnancy. Clin Immunol 2012;145:161-73.
39. Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H, et al. Protein expression and functional difference of membrane-bound and soluble receptor activator of NFkappa B ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun 2000;275: 768-75.
40. Lynch CC, Hikosaka A, Acuff HB, Martin MD, Kawai N, Singh RK, et al. MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell 2005;7:485-96.
41. Ikeda T, Kasai M, Utsuyama M, Hirokawa K. Determination of three isoforms of the receptor activator of nuclear factor-kappa B ligand and their differential expression in bone and thymus. Endocrinology 2001;142:1419-26.
42. Tang ZN, Zhang F, Tang P, Qi XW, Jiang J. Hypoxia induces RANK and RANKL expression by activating HIF-1a in breast cancer cells. Biochem Biophys Res Commun 2011;408:411-6.
43. Jones RL, Findlay JK, Farnworth PG, Robertson DM, Wallace E, Salamonsen LA. Activin A and inhibin A differentially regulate human uterine matrix metal-loproteinases: potential interactions during decidualization and trophoblast invasion. Endocrinology 2006;147:724-32.
44. Fernandez-Valdivia R, Mukherjee A, Ying Y, Li J, Paquet M, De Mayo FJ, et al. The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse. Dev Biol 2009;328: 127-39.
45. Wada T, Nakashima T, Hiroshi N, Penninger JM. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 2006;12:17-25.
46. Khorooshi R, Babcock AA, Owens T. NF-kappa B-driven STAT2 and CCL2 expression in astrocytes in response to brain injury. J Immunol 2008;181: 7284-91.
47. Li MQ, Hou XF, Lv SJ, Meng YH, Wang XQ, Tang CL, et al. CD82 gene suppression in endometrial stromal cells leads to increase of the cell invasiveness in the endometriotic milieu. J Mol Endocrinol 2011;47:195-208.
48. Chen TA, Wang JL, Hung SW, Chu CL, Cheng YC, Liang SM. Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 production. PLo S One 2011;6: e23317.
49. Zhou WH, Du MR, Dong L, Yu J, Li DJ. Chemokine CXCL12 promotes the crosstalk between trophoblasts and decidual stromal cells in human first-trimester pregnancy. Hum Reprod 2008;23:2669-79.
50. Li MQ, Tang CL, Du MR, Fan DX, Zhao HB, Xu B, et al. CXCL12 controls over-invasion of trophoblasts via upregulating CD82 expression in DSCs at maternal-fetal interface of human early pregnancy in a paracrine manner. Int J Clin Exp Pathol 2011;4:276-86.
51. Wu X, Jin LP, Yuan MM, Zhu Y, Wang MY, Li DJ. Human first-trimester trophoblast cells recruit CD56bright CD16-NK cells into decidua by way of expressing and secreting of CXCL12/stromal cell-derived factor 1. J Immunol 2005;175:61-8.
52. Piao HL, Tao Y, Zhu R, Wang SC, Tang CL, Fu Q, et al. The CXCL12/CXCR4 axis is involved in the maintenance of Th2 bias at the maternal/fetal interface in early human pregnancy. Cell Mol Immunol 2012;9:423-30.